Overview

Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction

Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of Kuntai capsule alone or combined with hormone therapy in improving ovarian function in POI patients (including subclinical stage).
Phase:
Phase 4
Details
Lead Sponsor:
Affiliated Hospital of Nantong University
Treatments:
Dydrogesterone
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Polyestradiol phosphate